Loading clinical trials...
Loading clinical trials...
This is a phase 1b, open-Label study of sorafenib with BIIB022 in subjects with advanced hepatocellular carcinoma.
Keep your clinical trial research organized — questions to ask, what to expect, and key details.
Lead Sponsor
Biogen
NCT07607769 · Hepatocellular Carcinoma
NCT07610551 · HCC - Hepatocellular Carcinoma
NCT07012798 · Hepatocellular Carcinoma (HCC)
NCT07478302 · Advanced Unresectable Hepatocellular Carcinoma
NCT07322848 · Hepatocellular Carcinoma (HCC), TACE, and more
Resesarch Site
Denver, Colorado
Resesarch Site
Ocoee, Florida
Resesarch Site
Indianapolis, Indiana
Use Clareo to keep notes, questions, trial details, and next steps organized before and after appointments.
Start free trial →Data Source & Attribution
This clinical trial information is sourced from ClinicalTrials.gov, a service of the U.S. National Institutes of Health.
Modifications: This data has been reformatted for display purposes. Eligibility criteria have been parsed into inclusion/exclusion sections. Location data has been geocoded to enable distance-based search. For the authoritative and most current information, please visit ClinicalTrials.gov.
Neither the United States Government nor Clareo Health make any warranties regarding the data. Check ClinicalTrials.gov frequently for updates.
View ClinicalTrials.gov Terms and Conditions